Edwin van der Zaag

2140P Active surveillance versus standard surgery after neoadjuvant chemoradiotherapy for oesophageal cancer: A cost-effectiveness analysis of the SANO-trial

Bianca Mostert, S. Gangaram-Panday, Berend J. van der Wilk, Ben M. Eyck et autres

nl (code pays fourni par la source)

2107P Health-related quality of life of patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO trial)

S. Gangaram-Panday, Berend J. van der Wilk, Sjoerd M. Lagarde, Camiel Rosman et autres

nl (code pays fourni par la source)

255. EXPLORING UNCERTAINTY OF RESTAGING AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER

Sanjiv Gangaram Panday, Dion In 't Veld, Sjoerd M. Lagarde, Bianca Mostert et autres

Abstract Background The Surgery As Needed for Oesophageal cancer (SANO) trial showed that 35% of patients with resectable, locally advanced esophageal carcinoma had a clinical complete response after neoadjuvant chemoradiotherapy (nCRT) and were eligible for active surveillance. However, the optimal approach for …

nl (code pays fourni par la source)

252. ACCURACY OF PREDICTING RESIDUAL DISEASE AND DISEASE PROGRESSION DURING ACTIVE SURVEILLANCE FOR ESOPHAGEAL CANCER

S Panday, David V. Klaveren, Sjoerd M. Lagarde, Hester Floor Lingsma et autres

Abstract Background In patients with esophageal cancer and a clinical complete response (CCR) after neoadjuvant chemoradiotherapy (nCRT) active surveillance is non-inferior to standard surgery. However, two-thirds of patients have residual disease detected 12 weeks after nCRT and proceed to surgery. In addition, …

nl (code pays fourni par la source)

258. OUTCOMES OF SURGERY IN PATIENTS WITH A NON-CLINICAL COMPLETE RESPONSE AFTER NCRT FOR ESOPHAGEAL CANCER

S Panday, Sjoerd M. Lagarde, Dion In 't Veld, Bianca Mostert et autres

Abstract Background The SANO trial showed non-inferior two-year overall survival for active surveillance versus standard surgery in patients with a clinical complete response (CCR) after neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer. However, the impact of delaying surgery to perform response evaluations and …

nl (code pays fourni par la source)

LBA75 Neoadjuvant chemoradiotherapy followed by surgery versus active surveillance for oesophageal cancer (SANO-trial): A phase-III stepped-wedge cluster randomised trial

Berend J. van der Wilk, Ben M. Eyck, Bas P. L. Wijnhoven, Sjoerd M. Lagarde et autres

nl (code pays fourni par la source)

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Toer W. Stevens, Maria L. Haasnoot, Geert D’Haens, Christianne Johanna Buskens et autres

nl (code pays fourni par la source)

897 RISK-STRATIFIED COMPARISON OF BRIDGE TO SURGERY APPROACHES VERSUS EMERGENCY RESECTION IN PATIENTS WITH LEFT-SIDED OBSTRUCTIVE COLON CANCER: A NATIONWIDE STUDY

Joyce Valerie Veld, Femke Julie Amelung, Wernard A. A. Borstlap, Emo E. van Halsema et autres

177 DECOMPRESSING STOMA VERSUS EMERGENCY RESECTION FOR LEFT-SIDED OBSTRUCTIVE COLON CANCER: A NATIONWIDE, PROPENSITY SCORE MATCHED STUDY

Joyce Valerie Veld, Femke Julie Amelung, Wernard A. A. Borstlap, Emo E. van Halsema et autres

Su1737 IS DECOMPRESSING STOMA A BETTER ALTERNATIVE THAN STENT AS BRIDGE TO SURGERY FOR LEFT-SIDED OBSTRUCTIVE COLON CANCER? A NATIONWIDE, PROPENSITY SCORE MATCHED ANALYSIS

Joyce Valerie Veld, Femke Julie Amelung, Wernard A. A. Borstlap, Emo E. van Halsema et autres

nl (code pays fourni par la source)

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis, Tjibbe J. Gardenbroek et autres

nl, gb (code pays fourni par la source)

Erratum to: Multicentre randomized controlled trial comparing ferric(III) carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients

WAA Borstlap, CJ Buskens, KMAJ Tytgat, Jurriaan B. Tuynman et autres

nl, ie (code pays fourni par la source)